Next Wave Academy Applications
The Next Wave of Clinical Investigators activity is a unique opportunity for young clinical investigators to engage with international thought leaders in chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL) in an intimate setting that educates these young investigators on tactics to expand their clinical research and impact the future of patient care.
- Registration at an in-person 1.5-day conference featuring sessions with leading CLL and NHL faculty on professional development as well as networking opportunities
- Travel to attend the conference and 2 nights’ accommodation at the venue hotel
- Matching with a mentor in their area of interest for regular touch points throughout the year
- Quarterly virtual meetings on professional development topics
- Reception to be held in-person at the American Society of Hematology (ASH) 2023 Annual Meeting and Exposition
A limited number of participants from industry will be in attendance both Friday, April 28 and Saturday, April 29. Interaction between industry representatives and the academy attendees will be limited.
Top 5 abstract submissions will also receive:
- An opportunity to present a 10-minute oral presentation during the conference
- Recognition as a top performer in the academy
- 1 additional applicant will be recognized for having the top presentation skills
- Applicants must be in their final 2 years of a fellowship program or within 5 years post-fellowship.
- Applicants must be US-based (MDs, MD/PhDs, and DOs) and currently employed in active patient care and patient-oriented clinical in CLL or NHL or being trained at an institution in the United States.
- Applicants must not be employed by a commercial pharmaceutical, biotech, or other biomedical company.
- Selected applicants must commit to actively participating in the program for the full year of activities.
- Individuals residing or working outside the United States at the time of application are not eligible.
- Individuals who are not participating in patient-oriented clinical research (e.g. preclinical research)
- Individuals who have received independent research funding at the time of application
- PhD only research fellows
- Recommendation letter from fellowship program director or clinical investigator in the field of CLL or NHL
- NIH Biosketch preferred (maximum 5 pages) or CV
- Brief video (2 minutes or less) explaining why they want to participate in the Next Wave Academy, demonstrating the applicants’ presentation skills and detailing their goals for the 1-year mentoring program
- Submission of an abstract for the conference
- The abstract should be a summary of a research plan for a future study
- Contribution to science: clear commitment to an academic oncology career through publication and project efforts, and training to date
- Clear goals: specific and achievable aims for the mentoring program
- Abstract quality: submitted abstract will be evaluated using the following criteria:
- Scientific importance: will this research make a difference in diagnosis, treatment, or quality of patient care?
- Quality of research: is the hypothesis feasible and will the stated methodology enable this research to be completed in a meaningful way?
- Enhance knowledge: will the research improve our knowledge about the disease or treatment
- Does the research answer a question that needs to be answered or provide new findings that may change the way we diagnose or treat a condition?
- Overall presentation of abstract: is the abstract informative and thoughtfully written; does it outline the question to be addressed; and is the research proposed able to provide an answer?